Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer.
Takchi A, Zhang M, Jalalirad M, Ferre RL, Shrestha R, Haddad T, Sarkaria J, Tuma A, Carter J, David H, Giridhar K, Wang L, Lange C, Lendahl U, Ingle J, Goetz M, D'Assoro AB.
Takchi A, et al. Among authors: zhang m.
Front Oncol. 2024 May 30;14:1384277. doi: 10.3389/fonc.2024.1384277. eCollection 2024.
Front Oncol. 2024.
PMID: 38873259
Free PMC article.